Director, Corporate Business Development

BioSpace; New York (NY); On-site; USD 150,000 - 210,000; Full time

Job summary

Immunocore, a pioneering biotechnology company, seeks a Director, Corporate Business Development to shape and execute the BD strategy, leading licensing, collaborations and M&A opportunities that complement its TCR platform and pipeline.

Reporting to the Head of Business Development, you will coordinate cross-functional due diligence, prepare investment cases for senior leadership, and build strategic partnerships with biotech companies, academia and investors worldwide.

Qualifications

• Strong scientific background paired with business acumen.
• Experience in scouting licensing, collaborations, and/or M&A in biotech/pharma.
• Proven deal making capability with a track record of closing transactions.
• Extensive network within biotech/pharma industries and related sectors.
• Knowledge of innovative alliance structures and industry trends in biopharma.

Responsibilities

• Proactively identify and evaluate external opportunities across oncology and autoimmune indications.
• Translate corporate strategy into actionable search criteria and pipeline improvements.
• Lead end-to-end transactions for licensing, collaborations, and acquisitions.
• Coordinate diligence across R&D, clinical, regulatory, manufacturing, commercial, legal, and finance teams.
• Prepare and present investment cases to senior leadership and executive committees.
• Develop and maintain strategic relationships with biotech companies, academia, investors.

Skills

Scientific background

Business acumen

Deal making

Cross-functional collaboration

Biotech industry knowledge

Education

Bachelor's degree in science/finance/business

Advanced degree (PhD/MBA) preferred

Job description

Vacancy Name

Director, Corporate Business Development

Vacancy No

VN806

Employment Type

Full Time

Location of role

Gaithersburg, MD, Radnor, PA, Boston, MA, New York, NY

Department

Corporate

Main Purpose Of Job

Immunocore is a commercial-stage biotechnology company that discovered the world’s first approved T cell receptor (TCR) therapy. The company is experiencing growth through commercialization of that TCR therapy and has an impressive and innovative pipeline of new medicines in Oncology, Autoimmune Diseases, and Infectious Diseases. The company has had very impressive growth to date, with further and aspiring growth plans enabled by the potential launch of new indications and medicines.

Immunocore has ambitious growth objectives in Corporate Business Development. This involves the identification of key strategic partnerships globally that will include licensing-based collaborations, mergers and acquisitions (M&A), and commercial partnerships. These are all important components of the strategy of the company.

Reporting to the Head of Business Development, the Director Corporate Business Development will be a key member of the team responsible for both shaping and executing on the Business Development strategy to drive Immunocore’s growth. This individual will lead the identification, evaluation, and execution of licensing, collaboration, and M&A opportunities that complement and expand Immunocore’s TCR platform and therapeutic pipeline. The role requires a sophisticated blend of scientific literacy, financial acumen, deal making skills and the ability to operate effectively in a highly cross-functional global organization.

The role offers the opportunity to directly influence corporate strategy and shape the future pipeline at Immunocore, with meaningful visibility to senior leadership and tangible impact on patient outcomes.

Key Responsibilities

• Proactively identify and evaluate external opportunities across oncology, and autoimmune indications, including platform technologies, early-stage assets, and late-stage/commercial products;
• Translate corporate strategy into actionable search criteria; assessing how opportunities enhance Immunocore’s pipeline, platform capabilities, or commercial footprint;
• Lead transactions end-to-end, including initial outreach, term sheet development, negotiation, and contract execution for licensing, collaborations, and acquisitions;
• Coordinate diligence efforts across R&D, clinical, regulatory, manufacturing, commercial, legal, and finance teams;
• Prepare and present investment cases to senior leadership and executive committees; support Board-level materials as needed;
• Develop and maintain strong relationships with biotech companies, academic institutions, venture investors, and advisors to position Immunocore as a partner of choice.

Supervisory Responsibility

• None

Essential Qualifications

• Ideal candidate must have strong scientific background paired with business acumen;
• Bachelors degree in science, finance, business administration, or related field;
• Keen understanding of biological therapeutics, including evaluation of both pre-clinical and clinical stage opportunities in oncology and/or immunology;
• Experience scouting for innovative drug development partnerships including both academic and commercial partners;
• A deal sheet demonstrating execution of deals across a diverse range of deal types and structures (e.g. in- and out-licenses, platform deals, research collaborations);
• Established network within the industry;
• Well-developed knowledge of innovative alliance structures, industry trends, and competitive issues related to biopharma Business Development;
• Must demonstrate scientific knowledge and gravitas to hold/drive meaningful scientific discussions with both internal and external experts;
• Drives to solutions on significant and unique complex issues where problems are not clearly defined.

Preferred Qualifications

• Advanced degree (PhD/MBA) with background in life sciences
• Exposure to drug discovery or drug development in oncology
• Minimum 10 years of experience in biotech or pharma business development (search & evaluation), venture capital investing, or life sciences consulting, or other relevant experience

Other

• This role reports directly to the VP Head of Business Development;
• Travel is required

About The Company

Immunocore (NASDAQ: IMCR) is a pioneering, commercial-stage T cell receptor biotechnology company whose purpose is to develop and commercialize a new generation of transformative medicines which address unmet patient needs in oncology, infectious diseases and autoimmune disease. Our leaders in R&D are internationally recognised as some of the biotech industry’s most successful drug developers. We are creating not just an environment where great minds can interact but an innovation powerhouse answering the big questions.

Focused on delivering first-in-class biological therapies to patients, we have developed a highly innovative soluble TCR platform. Our ImmTAX molecules underpin a new generation of precision engineered drugs that harness the immune system to treat a broad spectrum of diseases with high unmet medical need, including oncology, infectious diseases and autoimmune diseases.

At Immunocore, we recognize that our employees are our greatest asset. We value the unique contributions each person brings to our team. By embracing Science, Trust, Respect, Integrity, Diversity, and Entrepreneurship (STRIDE), we create an environment where collaboration thrives, ideas flourish, and transformative changes happen. STRIDE represents more than just letters; it embodies our shared identity and drives our mission. We are dedicated to developing breakthrough therapies that transform patients’ lives, advancing medicine, and supporting one another in these pursuits.

Immunocore is proud to be an equal opportunity employer. As such, we are committed to fostering an inclusive workplace where everyone feels valued, respected, and empowered. We encourage applications from individuals of all backgrounds, regardless of race, color, religion, sex, sexual orientation, gender identity or expression, pregnancy, age, national origin, disability status, or any other characteristic protected by law.